Grand Rapids Public Museum

Shifting Perspectives: Harm Reduction Staff Perceptions of Drug Checking Implementation

Kaitlyn Jaffe, Whitney Ludwig, Steve Alsum, Nick DeHaan et autres

BACKGROUND: As the overdose crisis continues to devastate communities, expanding access to harm reduction services, such as drug checking, is essential. Drug checking services (DCS) enable people who use drugs (PWUD) to identify the likely active ingredients within their substances, supporting safer …

us (code pays fourni par la source)

More than Medicine: The Complex Choreography of Community Overdose Response

Adams L. Sibley, David C. Colston, Elizabeth Joniak-Grant, Blair Coleman et autres

us, th (code pays fourni par la source)

Sedimentology, petrography, and carbon isotopes of the ∼ 2.2 Ga Kona Dolomite, Upper Peninsula of Michigan

Maya L. Giannecchini, Garrett D. Brown, Cory M. Redman, Ian Z. Winkelstern et autres

us (code pays fourni par la source)

Epigenetic sperm quality testing for predicting fertility treatment success: a real-world and multi-site analysis

Kristin Brogaard, Susan B. A. Hudson, Carrie E. Bedient, Abby C Eblen et autres

PURPOSE: Infertility affects 1 in 6 couples, yet male fertility assessments often rely on semen analysis alone, which has limited predictive value for treatment success. This study evaluates an epigenetic tool for assessing sperm quality, aiming to provide a more comprehensive view …

us (code pays fourni par la source)

Ecological Silviculture in an Era of Climate Change

Brian J. Palik, Anthony W. D’Amato

us (code pays fourni par la source)

Abstract C095: [212Pb]VMT-a-NET for somatostatin receptor subtype 2 (SSTR2)-expressing tumors: safety and preliminary efficacy results in patients with advanced neuroendocrine tumors (NETs)

Vikas Prasad, Richard L. Wahl, Lilja B. Sólnes, Savitha Balaraman et autres

Abstract Background: [212Pb]VMT-a-NET is an alpha therapy agent targeting somatostatin receptor subtype 2 (SSTR2)-expressing tumors. Neuroendocrine tumors (NETs) generally express SSTR2 on their cell surface. Here, we report the results of a prospective, open-label, Phase I/IIa clinical trial evaluating the safety, tolerability, …

us (code pays fourni par la source)

A brick to a bundle: A qualitative study of behavioral responses to xylazine adulteration

Adams L. Sibley, Colin W. Miller, Elizabeth Joniak-Grant, Alice Bell et autres

BACKGROUND: Xylazine, a veterinary tranquilizer, has emerged as a widespread adulterant in the U.S. illicit drug supply, detected in over 90 % of street fentanyl samples in some regions and identified in a growing number of overdose deaths. While xylazine's health risks …

us (code pays fourni par la source)

Sedimentology, petrography, and carbon isotopes of the ∼2.2 Ga Randville Dolomite, Upper Peninsula of Michigan

Garrett Wallace Brown, Maya L. Giannecchini, Cory M. Redman, Ian Z. Winkelstern et autres

us (code pays fourni par la source)

Caring and Sharing: Keys to the ELF Program

Anna J. Small Roseboro

us (code pays fourni par la source)

Obesity Surgery Response to Letter to the Editor

Jon L. Schram, John R. Morton

us (code pays fourni par la source)

In Pursuit of Person-Centered Medicine: How Do People with Type 2 Diabetes Choose Glucose-Lowering Medications? A Qualitative Study

Elizabeth H. Golembiewski, Xinyuan Ning, Mindy M. Mickelson, Janet P. Gockerman et autres

us (code pays fourni par la source)

A Brick to a Bundle: Does Xylazine Paradoxically Contribute to Treatment-seeking and Reduced Fentanyl Use?

Adams L. Sibley, Colin W. Miller, Elizabeth Joniak-Grant, Alice Bell et autres

Abstract Background Xylazine is a veterinary tranquilizer found in the unregulated drug supply in the United States. It appears alone or as an adulterant in fentanyl (“tranq dope”). Xylazine’s symptomatology is well described and includes skin and soft tissue damage, bradycardia, and …

us (code pays fourni par la source)